CD274 and neoplasm: Treatment with anti-PD-L1 antibodies reduced tumor growth in the treated mice compared with the controls by 65% (Fig. 4a), which is in line with previous studies showing that MC38 responds well to PD-1/PD-L1 blockade therapy37,38.